The current study included 358 patients, all of whose CHA 2 DS 2 -VASc and CHA 2 DS 2 -VASc-HS scores were greater in the ISR group than the non-ISR group, but the differences did not reach statistical significance.
← all excerpts
CHA<sub>2</sub>DS<sub>2</sub>-Vasc score and CHA<sub>2</sub>DS<sub>2</sub>-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.
1
—
—